Linktree - our favorite links

NEW: Cozy Butter GLP-1 Community! Join Free
https://cozybutter.com/
A GLP-1 community where support isn’t at the mercy of the algorithm.
- Live GLP-1 support groups
- Live support groups and social events
- Health coaching and expert Q&As
- Cooking, movement, and stress-management classes
- Practical GLP-1 tools and guidance (water, protein, side effect management, etc.)
- A dedicated community beyond the algorithm

Book at 1 on 1 with Kim

______________________________________________________________________

The World Has More GLP-1s but Who Can Afford Them? Part 1

This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication.

Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world.

In Part 1, we discuss:
• How fat functions in the body and why it is considered an organ
• GLP-1 access, costs and treatment criteria in Ireland
• Which obesity medications were available in Ireland
• Differences between obesity care in Ireland and the United States
• Weight bias in healthcare and society
• Why obesity requires medical care, not more blame

Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience using GLP-1 medication and navigating obesity care.

CONNECT WITH OUR GUESTS

Dr. Michael “Mick” Crotty
My Best Weight
https://www.mybestweight.ie/
Instagram
https://www.instagram.com/mybestweight.ie/
LinkedIn
https://ie.linkedin.com/in/drmichaelcrotty

Belinda Hogan
Instagram
https://www.instagram.com/mid.life.insights/
The Dose with Paddy and Belinda
https://linktr.ee/TheDosePodcast

SOURCES
Oral Wegovy launches in Germany
https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/
Hims & Hers expands its GLP-1 services into Australia
https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/
600,000 people sign up for the Medicare obesity drug program
https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/
Employer GLP-1 coverage fell in 2026
https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/
PepsiCo and other employers cut GLP-1 coverage
https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790
Medicare enrollment data
https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment

______________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

The Podcast Promo Ad

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Linktree for Community Resources
https://linktr.ee/theplussidez

Join our free GLP-1 Community!
www.CozyButter.com 

Book a 1 on 1 Session with Kim - Code PLUS10 to save
https://calendly.com/theplussidez/kim

______________________________________________________________________
GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications?

What role has the food industry played in obesity, and how are GLP-1 medications changing what companies put on grocery store shelves?

Food scientist Liam Kincaid joins Kim and Bear to take us inside the science and psychology of food. They explore what makes certain foods easy to overeat, why novelty keeps us coming back, and whether sugar, preservatives, or any single ingredient deserves the blame.

Liam also explains why the grams of protein on a label do not tell the whole story, how to identify higher-quality protein sources, and why adding protein does not automatically make something “GLP-1 friendly.”

Plus, they discuss how GLP-1s can change cravings and food preferences, whether the food industry is trying to work around the medications’ effects, and why fiber, savory flavors, and entirely new products may shape the future of food.

This is an honest conversation about food, biology, access, and why people living with obesity deserve better than blame or another shiny label.

Follow Liam:

LinkedIn https://www.linkedin.com/in/liam-kincaid-ba498022a

TikTok https://www.tiktok.com/t/ZP87VgedS/

APOTHIKS Food Consulting https://www.apothiks.com 
_____________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

The Podcast Promo Ad

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Join a Paid Support Group -  Coupon Code PLUS30
Book It Here

*This episode discusses eating disorders, disordered eating, substance use, body image, and other sensitive topics. Please take care of yourself while listening.

In Part 2 of Kat's conversation with Nanette Adams, MEd, LPC, LMHC, they have a candid discussion about eating disorders, substance use, and obesity care from both a professional and lived-experience perspective.

Nanette is a therapist specializing in obesity and eating disorders, an obesity advocate, and a person living with obesity who has experienced both bariatric surgery and GLP-1 treatment herself. Together, she and Kat explore how our relationships with food, movement, our bodies and other coping behaviors can change throughout obesity treatment, and why eating disorders can be particularly difficult to recognize when weight loss is being celebrated.

You'll leave with a better understanding of how eating disorders and substance use can intersect with obesity treatment, why they can be missed in higher-weight bodies, and when you or someone you love may need additional support.

Connect with Nanette:
Weighted Wisdoms: https://weightedwisdoms.com
Substack: https://weightedwisdoms.substack.com
Instagram: @nanetteadamslpc
TikTok: @weightedwisdoms
Facebook: Weighted Wisdoms

Support & Resources
If you or someone you love is struggling with an eating disorder, disordered eating, substance use or mental health, support is available.
National Alliance for Eating Disorders
Therapist-staffed helpline: 866-662-1235
Monday–Friday, 9 a.m.–7 p.m. ET
Find treatment and eating disorder support:
https://www.findedhelp.com/
https://www.allianceforeatingdisorders.com/
SAMHSA National Helpline
1-800-662-HELP (4357)
Free, confidential treatment referral and information, available 24/7.
https://www.samhsa.gov/find-help/helplines
https://findtreatment.gov/
If you are in crisis: Call or text 988 for the 988 Suicide & Crisis Lifeline. If you are experiencing a medical emergency or are in immediate danger, call 911.

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Linktree for Community Resources

NEW From The Plus SideZ!

Need extra help on your GLP-1 Journey? We have options!
Live Patient Group with Kim
Sign up here:
Save with Code PLUS10

One-on-One Session with Kim
Schedule here:
Save with Code PLUS15
_____________________________________________________________

GLP-1 & Weight Regain: Why We Blame Ourselves

When weight regain happens, most people ask, "What am I doing wrong?" Weight regain can happen during GLP-1 treatment, after bariatric surgery, or years into an obesity journey. For many, the first response is self-blame.

Licensed therapist, obesity advocate, and person living with the disease of obesity, Nanette Adams, shares her personal journey while exploring why obesity is a chronic disease, how treatment often evolves over time, and the emotional toll of stalls, plateaus, and weight regain. We discuss therapy, shame, self-compassion, and why long-term support matters.

About Our Guest
Nanette Adams, LPC, LMHC is a licensed therapist, obesity advocate, and person living with the disease of obesity. Through her platform, Weighted Wisdoms, she combines professional expertise with lived experience to help people better understand obesity, weight stigma, and the emotional side of long-term treatment.

Connect with Nanette
Website
https://weightedwisdoms.com

Substack
https://weightedwisdoms.substack.com

Instagram
https://www.instagram.com/nanetteadamslpc/

TikTok
https://www.tiktok.com/@weightedwisdoms

Facebook
http://www.facebook.com/weightedwisdoms


_____________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Sign Up for Our Plus SideZ GLP-1 Patient Support Group - $50

https://forms.gle/aHvZiiBXFr6q7NQY7 

Linktree Our Favorite Things

https://linktr.ee/theplussidez

GLP-1 News: New Studies, Lawsuits & Compounding

What do the latest GLP-1 studies actually mean for patients?

This week, Kim is joined by Maria Rising, GLP-1 advocate, creator of GLP-1 News Now, our special guest News Correspondent. After living with PCOS and surviving a stroke in her 20s, Maria became passionate about helping patients understand the science behind obesity, GLP-1 medications, and access to care.

There isn't just one new GLP-1 study every week anymore. There are dozens. Maria follows the research, policy changes, and industry news so patients don't have to. Together, Kim and Maria break down the latest headlines and explain what they actually mean for people living with obesity and metabolic disease.

In this episode:

- Maria's journey with PCOS, stroke, and GLP-1 treatment

- The latest GLP-1 studies and research

- Compounding updates and current lawsuits

- What new research means for patients

- Obesity, metabolic health, and access to care

- How to separate headlines from evidence

For ongoing GLP-1 news, research, and access updates, be sure to subscribe to Maria's Substack and TikTok.

TikTok: https://www.tiktok.com/@tirzepatidetales

Substack: https://glp1newsnow.substack.com

The Plus SideZ Podcast is an educational podcast focused on obesity, metabolic health, and GLP-1 medications. This episode is for informational purposes only and is not medical advice. Always talk with your healthcare provider about questions regarding your treatment.

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Join our GLP-1 Support Group

______________________________________________________________________

"Both Our Advice and that of our Guest Expertalong with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you."

A Note Before You Listen: Our guest uses the term fat rather than obesity because that's the language of her community. At The Plus SideZ, we believe listening to different perspectives helps us better understand one another. If this language doesn't feel right for you, it's okay to honor that boundary and skip this episode.

The GLP-1 and body positivity communities are often portrayed as being at odds. But do they share more common ground than we realize?

In this episode, we sit down with Tigress Osborn, Executive Director of the National Association to Advance Fat Acceptance (NAAFA), to better understand the fat acceptance movement, the language it uses, and how it views obesity, GLP-1 medications, healthcare, body image, and weight stigma. 

Together, we explore where these communities differ, where they overlap, and whether listening to one another can lead to greater understanding.

Whether you agree or disagree, our goal isn't to debate or sway. It's to listen, learn, consider a different perspective, and better understand one another. 

Follow Tigress 

Instagram - https://www.instagram.com/iofthetigress/?hl=en 

Here book - https://www.amazon.com/Weight-Wisdom-Reflections-Decades-Liberation-ebook/dp/B0DRZ9R6XN

Learn more about Tigress Osborn and NAAFA:

• NAAFA: National Association to Advance Fat Acceptance (NAAFA)

• Socials: @naafaofficial

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? 

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

*Both Our Advice and that of our Guest Experts along with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you.

This is a rapid fire FAQ about the Medicare Bridge Program and coverage of  with an obesity Doctor.

 Dr. Michael Albert an Obesity Medicine Specialist joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:

• Who qualifies
• How the program works
• How to apply
• Options if you don't qualify

He also discusses:

• Weight loss with GLP-1s in older adults
• Protecting muscle mass and prioritizing protein
• Side effects to watch for
• What to advocate for with your doctor

Whether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.

Follow Dr. Michael Albert

Instagram and TikTok:
 @michaelalbertmd

Website:
 MichaelAlbertMD.com
______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? 

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

"Both Our Advice and our Guest Expert insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you."

How GLP-1s Broke Diet Culture

For decades, we believed weight gain and weight loss were mostly about willpower, calories, and exercise. Today, we’re learning there’s much more happening beneath the surface. The biology that drives hunger, metabolism, weight gain, and long-term health is far more complex than we once understood.

In this episode, Dr. Chiadi Ndumele, preventive cardiologist at Johns Hopkins Medicine and a leader with the American Heart Association, explains why GLP-1 medications work, how weight, metabolism, and chronic disease are connected, and why the first-ever Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline represents a major shift in how we understand and treat weight-related disease. You’ll also hear a powerful patient story that shows why this new understanding is giving hope to millions.

In this episode:

• Why GLP-1 medications work when diets often don’t.
• What really drives weight gain, weight loss, and long-term weight management.
• How metabolism, hormones, genetics, and overall health work together.
• Why understanding your body can help you advocate for the quality care you deserve.

Guest

Dr. Chiadi Ndumele

• Preventive Cardiologist, Johns Hopkins Medicine
• Chair, 2026 American Heart Association/American College of Cardiology Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline

Resources

American Heart Association: New Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline
https://www.heart.org/en/news/2026/06/09/new-ckm-guideline-urges-early-weight-talks-to-prevent-health-risks

Professional Heart Daily: 2026 Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
https://professional.heart.org/en/science-news/2026-guideline-for-the-prevention-detection-evaluation-and-management-of-ckm-syndrome

American Heart Association News Release: First-Ever Clinical Practice Guideline for Cardiovascular-Kidney-Metabolic Syndrome
https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials?

www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials 

______________________________________________________________________

While Kim takes time away following the loss of her sister, we're revisiting some of our most impactful conversations from Season 1. Thank you for supporting The Plus SideZ Podcast and this community during this time.

Why do GLP-1 medications work when years of dieting and exercise often don't?

In this episode, obesity medicine physician Dr. Matea Rentea explains why obesity is more than willpower. Through expert insight and a powerful patient story, we explore the science behind obesity, metabolism, hormones, and why "eat less, move more" often isn't enough.

In this episode:
• Why diets fail for many people living with obesity
• How hormones and metabolism affect weight loss
• Why GLP-1 medications work differently
• The role of exercise, mental health, and weight stigma
• Real patient experiences alongside evidence-based medicine

Whether you're new to GLP-1s or have been with us since Season 1, this conversation remains one of our most requested episodes.

This episode was originally recorded in Season 1. Medical information reflects what was known at the time of recording. Always talk with your healthcare provider before making medical decisions. 

Follow Dr. Rentea
https://www.renteaclinic.com/ 

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Resources for the Community:

___________________________________________________________________

Linktree Our Favorite Things

Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim

Find Your US Representatives 

https://www.usa.gov/elected-officials ______________________________________________________________________

Can GLP-1s Affect Food Noise, Alcohol, and Addiction?

** While Kim takes time away following the passing of her sister, we're revisiting some of our most impactful conversations. Thank you for your kindness, patience, and continued support of The Plus SideZ Podcast.

We're sharing this episode because it's more relevant today than when it first aired. Since then, research has expanded interest in whether GLP-1 medications may affect more than weight loss, including food noise, alcohol cravings, and other compulsive behaviors. While the science continues to evolve, so does the conversation.

Licensed therapist and addiction treatment leader Dr. Joy Bracey joins community member Brenda, who shares how Mounjaro changed her relationship with food, alcohol, and smoking. Together, they discuss the brain, behavior, and why this emerging area of research is drawing growing interest.

**In this episode:**

• Brenda's journey with obesity, binge eating, alcohol, smoking, and Mounjaro
• Food noise, binge eating, and emotional eating
• GLP-1 medications, dopamine, and the brain
• Alcohol cravings and addictive behaviors
• Mental health, self-love, and healing
• Why researchers are studying GLP-1 medications beyond weight loss

*Originally recorded during Season 1. This episode reflects the information available at the time of recording. Research and clinical guidance have continued to evolve. It is intended for education and discussion only and is not medical advice. Always consult your healthcare provider regarding your individual care.*

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories

Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram